Asterias Provides 24 Month Cohort 2 Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury
Asterias Biotherapeutics Announces New Exclusive License Agreement with The Regents of the University of California
Asterias Biotherapeutics Granted Orphan Drug Designation for AST-OPC1 for the Treatment of Acute Spinal Cord Injury
Spartan Metals' Exploration Program Confirms Tungsten Skarn Discoveries at past Producing Mine at Eagle Project, Nevada
Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
